Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bayer, Novartis Vying for Sanofi Animal Health Assets, FTD Says
Bloomberg
Monday, December 20, 2010 - 9:54am
tags:
Bayer, Novartis, animal health, Sanofi
Novartis Commits $500 Million to Russia
TheStreet.com
Monday, December 20, 2010 - 9:51am
tags:
Russia, Novartis
EpiTherapeutics, Abbott Form Cancer-Drug Research Partnership
Bloomberg
Monday, December 20, 2010 - 9:51am
tags:
EpiTherapeutics, Abbott Laboratories, cancer, epigenetics
Health Care Stocks: Winners vs. Losers (video)
The Street
Sunday, December 19, 2010 - 12:17pm
tags:
investors
Another Disappointment for Eli Lilly: Worries Freeze Melanoma Trial
Seeking Alpha
Sunday, December 19, 2010 - 12:16pm
tags:
Eli Lilly, melanoma, tasisulam
AstraZeneca's Blood-Thinner Hits Another FDA Roadblock as Company Faces Patent Cliff
Seeking Alpha
Sunday, December 19, 2010 - 12:15pm
tags:
AstraZeneca, Brilinta, blood thinners
Respiratory Stocks (ITMN, KV.A, RMD, NKTR, ISPH)
College Stock
Sunday, December 19, 2010 - 12:12pm
tags:
ResMed, KV Pharmaceutical, InterMune, Inspire, Nektar
Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) Surges 40.22% in Past 1 Month Trading Sessions
College Stock
Sunday, December 19, 2010 - 12:11pm
tags:
Alexza, investors
Pharmaceutical companies push for social-media rules
Seer Press
Sunday, December 19, 2010 - 12:00pm
tags:
social media
FDA may charge to inspect faster
Fort Wayne Journal Gazette, IN
Sunday, December 19, 2010 - 11:56am
tags:
FDA
Big Pharma's small voice (in social media)
Delaware Online, DE
Sunday, December 19, 2010 - 11:55am
tags:
social media, Big Pharma
Lawsuit by 2 women over breast cancer and hormone therapy to begin next month in Washoe County against drug firms
Reno Gazette Journal, NV
Sunday, December 19, 2010 - 11:53am
tags:
Wyeth, Pfizer, Premarin, Prempro, Provera, Upjohn, breast cancer
Adventrx Requests Meeting with FDA to Discuss ANX-514 Study
PR-USA
Sunday, December 19, 2010 - 11:34am
tags:
Taxotere, cancer, ANX-514, Adventrx
Celator Pharmaceuticals announces US patent related to technology platform
istockanalyst
Sunday, December 19, 2010 - 11:33am
tags:
Celator, Nanotechnoogy, nano-scale liposomes, cancer
Collins Stewart Analysts Downgrade Alcon, Inc. (NYSE: ACL) to “Hold”
American Consumer News
Sunday, December 19, 2010 - 11:30am
tags:
Alcon, investors
The codeine regulations: a bitter pill to swallow? (in Ireland)
Lexology
Sunday, December 19, 2010 - 11:26am
tags:
regulatory
Three Upcoming Make-or-Break Biotech Approvals
Seeking Alpha
Sunday, December 19, 2010 - 11:22am
tags:
Vertex Pharmaceuticals, Telaprevir, Merck, hepatitis C, cystic fibrosis, Human Genome Sciences, Benlysta, lupus, MannKind, Afrezza, inhaled insulin
Cytokinetics: Most Recent Victim of Unjustified Biotech Sell-Off
Seeking Alpha
Sunday, December 19, 2010 - 11:18am
tags:
Cytokinetics, biotech, investors
ThinkEquity Analysts Lower Price Target on Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) Shares to $20.00
American Consumer News
Saturday, December 18, 2010 - 1:58pm
tags:
Cubist Pharmaceuticals, investors
CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA
PR-Canada.net
Saturday, December 18, 2010 - 1:55pm
tags:
Celtic Therapeutics, Bellus Health, Kiacta, AA amyloidosis, rheumatoid arthritis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.